Randomized, concentration-controlled trial of topiramate in refractory focal epilepsy

Neurology

Volumn 61, Issue 9, 2003, Pages 1210-1218

  Christensen, Jakob ^a   Andreasen, Frederik ^a   Poulsen, Jørgen Hjelm ^a   Dam, Mogens ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TOPIRAMATE;

ABDOMINAL PAIN; ADULT; AGGRESSION; AMNESIA; ANXIETY DISORDER; APPETITE DISORDER; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIPLOPIA; DRUG BLOOD LEVEL; DRUG EFFICACY; FATIGUE; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HEADACHE; HEART INFARCTION; HUMAN; INTELLECTUAL IMPAIRMENT; LEG PAIN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL DISEASE; NAUSEA; NEPHROLITHIASIS; OUTCOMES RESEARCH; PARESTHESIA; PERSONALITY DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SEIZURE; SIDE EFFECT; SLEEP DISORDER; THROMBOPHLEBITIS; VERTIGO; VISUAL DISORDER;

EID: 0242494505     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000091867.09720.6B     Document Type: Article

References (18)

1. Privitera M, Fincham R, Penry J, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1, 000-mg daily dosages. Topiramate YE Study Group. Neurology 1996;46:1678-1683.
2. Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group. Neurology 1996;46:1684-1690.
3. Sharief M, Viteri C, Ben Menachem E, et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 1996;25:217-224.
4. Tassinari CA, Michelucci R, Chauvel P, et al. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996;37:763-768.
5. Ben Menachem E, Henriksen O, Dam M, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996;37:539-543.
6. Gram L, Flachs H, Würtz-Jørgensen A, Parnas J, Andersen B. Sodium valproate, serum level and clinical effect in epilepsy: a controlled clinical study. Epilepsia 1979;20:303-312.
7. Tomson T, Johannessen SI. Therapeutic monitoring of the new antiepileptic drugs. Eur J Clin Pharmacol 2000;55:697-705.
8. Perucca E. Is there a role for therapeutic drug monitoring of new anticonvulsants? Clin Pharmacokinet 2000;38:191-204.
9. Jorgensen A, Fabricius S, Nexo E, et al. The GCP-unit at the Aaarhus University Hospital. Ugeskr Laeger 2000;162:4288-4290.
10. Christensen J, Hojskov CS, Poulsen JH. Liquid chromatography tandem mass spectrometry assay for topiramate analysis in plasma and cerebrospinal fluid: validation and comparison with fluorescence-polarization immunoassay. Ther Drug Monit 2002;24:658-664.
11. Innofluor Topiramate Assay System package insert, OXIS International, Portland, OR, 2001.
12. Unnebrink K, Windeler J. Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Stat Med 2001;20:3931-3946.
13. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998;39:5-17.
14. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319.
15. Bernus I, Dickinson RG, Hooper WD, Eadie MJ. Anticonvulsant therapy in aged patients-clinical pharmacokinetic considerations. Drugs Aging 1997;10:278-289.
16. Guberman A, Neto W, Gassmann-Mayer C. Low-dose topiramate in adults with treatment-resistant partial-onset seizures. Acta Neurol Scand 2002;106:183-189.
17. Stephen LJ, Sills GJ, Brodie MJ. Lamotrigine and topiramate may be a useful combination. Lancet 1998;351:958-959. Letter.
18. Biton V, Edwards KR, Montouris GD, Sackellares JC, Harden CL, Kamin M. Topiramate titration and tolerability. Ann Pharmacother 2001;35:173-179.